(Q28749049)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20922062%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Drug Discovery in Academia- the third way? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20922062%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20922062%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Julie Frearson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20922062%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

language of work or name

English

0 references

publication date

1 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20922062%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Discovery

15 February 2020

published in

3 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20922062%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20922062%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20922062%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

909-919

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20922062%20AND%20SRC:MED&resulttype=core&format=json

Thousands of chemical starting points for antimalarial lead identification

15 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948567

N-myristoyltransferase inhibitors as new leads to treat sleeping sickness

16 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948567

How to improve R&D productivity: the pharmaceutical industry's grand challenge

16 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948567

Virus-free induction of pluripotency and subsequent excision of reprogramming factors

16 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948567

Network pharmacology: the next paradigm in drug discovery

16 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948567

Drug discovery in jeopardy

16 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948567

The need for precompetitive integrative bionetwork disease model building

16 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948567

The Critical Path Institute's approach to precompetitive sharing and advancing regulatory science

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948567

The future is much closer collaboration between the pharmaceutical industry and academic medical centers

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948567

Highlights in the discovery of antiviral drugs: a personal retrospective

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948567

HTS and hit finding in academia--from chemical genomics to drug discovery

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948567

Drug discovery: new models for industry-academic partnerships

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948567

Building a pharmacological lexicon: small molecule discovery in academia

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948567

2007 FDA drug approvals: a year of flux.

3 June 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2010.506508

Pharmaceutical sciences in 2020.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2010.506508

A Wellcome experiment in seeding drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2010.506508

Open innovation networks between academia and industry: an imperative for breakthrough therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2010.506508

Is open innovation the way forward for big pharma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2010.506508

How academia can help drug discovery

21 January 2018

1 reference

12 December 2020

Why academic drug discovery makes sense

1 reference

12 December 2020

Drug discovery through industry-academic partnerships

1 reference

12 December 2020

National origins of new drugs

1 reference

12 December 2020

Financing R&D for neglected diseases

1 reference

12 December 2020

10.1517/17460441.2010.506508

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20922062%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20922062%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

PubMed publication ID

20922062

1 reference